X0306 4 2023-03-03 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001878086 Inbar Galia C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 See "Remarks" Ordinary Shares 2023-03-04 4 M 0 20107 A 40301 D Ordinary Shares 2023-03-05 4 M 0 5710 A 46011 D Restricted Share Units 2023-03-03 4 A 0 59760 0.00 A Ordinary Shares 59760 59760 D Restricted Share Units 2023-03-04 4 M 0 20107 0.00 D Ordinary Shares 20107 60321 D Restricted Share Units 2023-03-05 4 M 0 5710 0.00 D Ordinary Shares 5710 11422 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027. Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025, and March 4, 2026. Restricted share units were granted on March 5, 2021, with 5,710 vested on each of March 5, 2022 and March 5, 2023, 5,710 vesting on March 5, 2024, and 5,712 vesting on March 5, 2025. EVP, Chief Human Resources Officer and Corporate Affairs /s/ Dov Bergwerk as attorney-in-fact for Galia Inbar 2023-03-07